Doctor profile · Federal record
Dr. Dean Papaliodis, M.D.
Sports Medicine (Orthopaedic Surgery) Physician (CMS: Sports Medicine) · Orthopaedic Surgery Physician · Fort Worth, TX
- NPI 1194041558
- Accepts Medicare
- MIPS 97.4 / 100 · 2023
- 16 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
5900 Altamesa Blvd Ste 100
Fort Worth, TX 761325473
(817) 854-9969
fax (817) 854-9965 - Additional location
-
640 Keller Parkway Suite 100
Keller, TX 762482559
fax (833) 604-0854
Credentials & registration
- NPI registered
- April 2010 — 16 yrs on file
- Profile last updated
- March 17, 2026
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 207XX0005X — NUCC code
- State license (1)
- Texas #Q8989
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1194041558. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,509
Distinct HCPCS
10
Medicare allowed
$225,654
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3304 |
Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 1,218 | 14 | $17 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 480 | 240 | $88 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 413 | 58 | $1 | |
20610 |
Aspiration and/or injection of fluid from large joint | 228 | 130 | $72 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 214 | 37 | $0 | |
73030 |
X-ray of shoulder, minimum of 2 views | 144 | 74 | $35 | |
73502 |
X-ray of hip, 2-3 views | 102 | 59 | $43 | |
73564 |
X-ray of knee, 4 or more views | 97 | 95 | $46 | |
J7327 |
Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | 82 | 53 | $705 | |
J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 67 | 37 | $7 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 397. This provider delivers 8.8× the peer median.Open Payments
Industry payments received
All-time total
$3,228
Transactions
33
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Stryker Corporation | 6 | $1,218.54 | |
| Arthrex, Inc. | 14 | $1,059.70 | |
| Pylant Medical | 5 | $336.03 | |
| ABANZA INC. | 2 | $270.93 | |
| Smith+Nephew, Inc. | 1 | $147.16 | |
| Medical Device Business Services, Inc. | 1 | $109.33 | |
| Bioventus LLC | 2 | $55.24 | |
| DePuy Synthes Sales Inc. | 1 | $17.86 | |
| Sanara MedTech Inc. | 1 | $13.30 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
347
Patients
243
Total drug cost
$3,219
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 70 | 44 | $694 |
| Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) | Brand | 57 | 48 | $763 |
| Methocarbamol | Generic | 49 | 32 | $484 |
| Diclofenac Sodium | Generic | 31 | 26 | $116 |
| Celecoxib | Generic | 30 | 20 | $711 |
| Tramadol Hcl | Generic | 30 | 20 | $95 |
| Cephalexin | Generic | 27 | 27 | $78 |
| Methylprednisolone | Generic | 26 | 26 | $220 |
| Amoxicillin | Generic | 16 | 0 | $14 |
| Clindamycin Hcl | Generic | 11 | 0 | $44 |
Hospital affiliations
Frequently asked questions
What is Dr. Dean Papaliodis's medical specialty?
Dr. Dean Papaliodis practices Sports Medicine (Orthopaedic Surgery) Physician in Fort Worth, TX.
Where does Dr. Dean Papaliodis practice?
Dr. Dean Papaliodis practices at 5900 Altamesa Blvd Ste 100, Fort Worth, TX 761325473. Office phone: 8178549969.
What is Dr. Dean Papaliodis's NPI?
Dr. Dean Papaliodis's National Provider Identifier (NPI) is 1194041558, issued by NPPES.
Does Dr. Dean Papaliodis accept Medicare assignment?
Yes. Dr. Dean Papaliodis accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Dean Papaliodis commonly perform?
Top Medicare-reported procedures in 2023: Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg (HCPCS J3304); Established patient office or other outpatient visit (HCPCS 99213); Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS J3301). Source: CMS Medicare Physician & Other Practitioners file.